cfitzgibbons
Networker
when Is it appropriate to use Z29.11 - Encounter for prophylactic immunotherapy for respiratory syncytial virus (RSV)? My manager (non certified coder) insists that this be used when I am strictly billing Synagis and nothing else. She just became my manager and up until this point, I have been coding conditions that would make the patient susceptible to RSV, chronic lung disease, etc. Any input would be appreciated.